Juliete Nathali Scholl

11PUBLICATIONS
44CO-AUTHORS
Cancer cell biologyEpigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2026
Integrating Transcriptomics and 3D Spheroid Models Reveals Microenvironment-Dependent Purinergic Modulation in Hepatocellular Carcinoma.

Arieli Cruz de Sousa, Augusto Ferreira Weber, Vinícius Klain

|Sep 13, 2025
Downregulation of miR-27a-3p Modulates TGF-β Signaling and Dysregulates Metabolism in Glioblastoma.

Augusto Ferreira Weber, Juliete Nathali Scholl, Camila Kehl Dias

|May 14, 2025
Assessing Ecto-5'-Nucleotidase/CD73 Expression and Malignancy Parameters in Early- and Late- Passage C6 Glioma Cells.

Fabiana M Manica, Luis Felipe I Campesato, Juliete Nathali Scholl

|Dec 19, 2024
In silico, in vitro, and ex vivo analysis reveals miR-27a-3p and miR-155-5p as key microRNAs for glioblastoma progression: Insights into Th1 differentiation and apoptosis induction.

Augusto Ferreira Weber, Juliete Nathali Scholl, Camila Kehl Dias

|Nov 25, 2023
Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer.

Carla Fernanda Furtado Gardani, Eduardo Luiz Pedrazza, Victória Santos Paz

|Mar 25, 2023
Characterization of purinergic signaling in tumor-infiltrating lymphocytes from lower- and high-grade gliomas.

Juliete Nathali Scholl, Augusto Ferreira Weber, Camila Kehl Dias

Pageof 2

Frequent Collaborators

10 joint publications

Fabrício Figueiró

7 joint publications

Ana Maria Oliveira Battastini

4 joint publications

Camila Kehl Dias

3 joint publications

Augusto Ferreira Weber